Diaz, Vecinta O.
HRN: 14 68 90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/27/2023
02/02/2023
IVT
4.5g
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes